Clinical Trial Update: A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Hypertensive Subjects [Phase 2]

View source ↗

Summary

Phase 2 study evaluating efficacy and safety of CS-3150 in Japanese subjects with essential hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• CS-3150 (CS-3150)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Essential Hypertension | Phase 2 | Status: COMPLETED